Beta carotene - Generic Drug Details

What are the generic drug sources for beta carotene and what is the scope of freedom to operate?

Beta carotene is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for beta carotene.

Summary for beta carotene

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	1
Raw Ingredient (Bulk) Api Vendors:	111
Clinical Trials:	35
DailyMed Link:	beta carotene at DailyMed

Recent Clinical Trials for beta carotene

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Universidad de Granada	EARLY_PHASE1
Dexa Medica Group	Phase 4
Duta Wacana Christian University	Phase 4

See all beta carotene clinical trials

Medical Subject Heading (MeSH) Categories for beta carotene

Provitamins

US Patents and Regulatory Information for beta carotene

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roche	SOLATENE	beta carotene	CAPSULE;ORAL	017589-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Beta Carotene Market Dynamics and Financial Trajectory

Last updated: February 19, 2026

Beta-carotene, a provitamin A carotenoid, occupies a niche within the broader dietary supplement and food fortification markets. Its primary function as a precursor to vitamin A underpins its demand, alongside its antioxidant properties. The market is characterized by stable, albeit moderate, growth driven by increasing consumer awareness of health and wellness, coupled with the functional benefits of vitamin A in vision, immune function, and skin health.

What is the Current Market Size and Projected Growth for Beta Carotene?

The global beta-carotene market was valued at approximately $500 million in 2022 and is projected to reach $700 million by 2030, exhibiting a compound annual growth rate (CAGR) of 4.5% during the forecast period. This growth is attributed to the expanding nutraceutical sector and the rising demand for dietary supplements.

• Regional Breakdown (2022 Estimates):

  • North America: $180 million
  • Europe: $150 million
  • Asia Pacific: $120 million
  • Rest of the World: $50 million

• Projected Growth Drivers:

  • Increased consumer spending on health and wellness products.
  • Growing adoption of fortified food products.
  • Rising prevalence of vitamin A deficiencies in developing regions.
  • Expanding applications in animal feed.

The market for beta-carotene is segmentable by source, with natural and synthetic forms catering to different industry needs and price points.

What are the Primary Applications and End-Use Industries for Beta Carotene?

Beta-carotene's utility spans several key industries, primarily driven by its role as a nutrient and its colorant properties.

• Dietary Supplements: This is the largest segment, accounting for approximately 60% of beta-carotene consumption. Consumers utilize supplements for their provitamin A activity and antioxidant benefits.
• Food and Beverages: Beta-carotene is used as a natural food colorant (E160a) and for vitamin A fortification in products such as dairy, cereals, and margarine. This segment represents about 30% of the market.
• Animal Feed: It is incorporated into animal feed to enhance the coloration of egg yolks and poultry meat, and to improve overall animal health. This segment accounts for roughly 10% of demand.
• Cosmetics and Personal Care: Emerging applications exist in skincare products for their antioxidant and potential UV-protective properties.

What are the Key Market Trends Influencing Beta Carotene Demand?

Several converging trends are shaping the beta-carotene market landscape.

• Shift Towards Natural Ingredients: Consumers increasingly prefer natural over synthetic ingredients, driving demand for naturally sourced beta-carotene. This preference impacts sourcing strategies and potentially pricing.
• Growth of the Nutraceuticals Sector: The expanding global nutraceutical market, driven by preventative healthcare and disease management, directly fuels demand for vitamin precursors like beta-carotene.
• Fortification Initiatives: Government and public health initiatives aimed at combating vitamin A deficiency, particularly in emerging economies, are significant drivers for beta-carotene in food fortification.
• Technological Advancements in Production: Innovations in extraction and synthesis methods are improving purity, yield, and cost-effectiveness of beta-carotene production. This includes advancements in microbial fermentation and plant-based extraction techniques.
• Sustainability Concerns: Increasing focus on sustainable sourcing and production methods is influencing raw material procurement and manufacturing processes.

What is the Competitive Landscape of Beta Carotene Producers?

The beta-carotene market is moderately concentrated, with a few key global players dominating production, alongside several regional manufacturers. Production is primarily driven by established chemical and ingredient companies.

• Key Manufacturers:
  • BASF SE (Germany)
  • DSM (Netherlands)
  • ADISSEO (France)
  • Zhejiang NHU Co., Ltd. (China)
  • Algatechnologies Ltd. (Israel)
  • Fenchem (China)

These companies compete on factors such as product quality, purity, pricing, supply chain reliability, and regulatory compliance. Strategic partnerships and acquisitions are also observed as companies seek to expand their market reach and product portfolios.

What are the Key Patents and Intellectual Property Developments in Beta Carotene?

Patent activity in the beta-carotene space focuses on improving production efficiency, enhancing bioavailability, developing novel formulations, and exploring new therapeutic or nutritional applications.

• Process Improvement Patents: These patents often claim novel or improved methods for the synthesis of beta-carotene, extraction from natural sources (e.g., algae, plants), and purification techniques to achieve higher yields and purity. For example, patents may detail specific microbial strains or fermentation conditions for increased carotenoid production.
• Formulation Patents: Innovations in how beta-carotene is delivered to enhance its stability and bioavailability are common. This includes microencapsulation technologies, emulsion formulations, and co-formulations with other nutrients or excipients. Improved absorption rates are a frequent claim.
• Application Patents: Patents are filed for new uses of beta-carotene, particularly in health and wellness. This can include its use in specific therapeutic areas, as an ingredient in functional foods targeting particular health benefits (e.g., eye health, immune support), or in cosmetic formulations with claims related to skin protection or rejuvenation.
• Source Development Patents: Research into and patenting of novel biological sources for beta-carotene, such as genetically modified microorganisms or specific plant varieties, is ongoing.

Example Patent Focus Areas:

• CN104982469A: A method for extracting beta-carotene from Dunaliella salina using supercritical CO2, aiming for higher purity and reduced solvent use. (Application Date: 2015-07-22)
• US20180290913A1: A formulation for enhanced beta-carotene absorption in dietary supplements, employing specific emulsifiers and excipients. (Application Date: 2018-04-12)
• WO2019012734A1: A patent detailing the use of beta-carotene in a synergistic combination with other antioxidants for photoprotection in cosmetic applications. (Application Date: 2018-07-18)

Companies invest in R&D to secure patent protection that provides exclusivity for their proprietary technologies and product formulations, creating barriers to entry for competitors.

What are the Regulatory Considerations for Beta Carotene?

The regulatory landscape for beta-carotene is multifaceted, involving food safety, labeling, and health claims across different jurisdictions.

• Food Additive Status: Beta-carotene is widely approved as a food colorant and nutrient fortification agent. In the European Union, it is designated as E160a and subject to Regulation (EC) No 1333/2008. In the United States, it is recognized as Generally Recognized As Safe (GRAS) by the FDA for food uses.
• Dietary Supplement Regulations: In the US, dietary supplements are regulated under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Manufacturers are responsible for ensuring the safety and accuracy of product labeling. Health claims are subject to strict review and must be substantiated.
• Nutrient Labeling: The amount of beta-carotene is often declared as a percentage of the Daily Value (%DV) for vitamin A, or in International Units (IU) or micrograms (mcg) of Retinol Activity Equivalents (RAE).
• International Harmonization: While general approvals exist globally, specific regulations regarding permitted sources, maximum usage levels, and acceptable claims can vary between countries and regions, requiring careful navigation for international market entry.
• Purity Standards: Manufacturers must adhere to pharmacopoeial standards (e.g., USP, EP) or food-grade specifications to ensure the quality and safety of beta-carotene used in food and supplements.

Compliance with these regulations is critical for market access and maintaining consumer trust.

What are the Financial Projections and Investment Opportunities for Beta Carotene?

The financial trajectory of the beta-carotene market indicates sustained, albeit moderate, profitability. Investment opportunities exist in areas that align with market trends and address unmet needs.

• Profitability Factors:

  • Stable Demand: Consistent demand from the food, supplement, and animal feed industries provides a reliable revenue base.
  • Technological Edge: Companies with patented, efficient production processes or superior bioavailability formulations can command premium pricing and margins.
  • Vertical Integration: Control over raw material sourcing and manufacturing can offer cost advantages and supply chain security.
  • Market Segmentation: Focusing on high-growth segments like premium nutraceuticals or specialized food applications can yield higher returns.

• Investment Opportunities:

  • Natural Beta Carotene Sourcing: Investments in sustainable cultivation of algae or specific plant sources for high-purity natural beta-carotene are promising, catering to consumer preference.
  • Bioavailability Enhancement Technologies: Companies developing novel delivery systems or formulations that significantly improve beta-carotene absorption present strong growth potential.
  • Emerging Market Penetration: Opportunities exist for companies to establish or expand their presence in regions with growing middle classes and increasing health consciousness, where vitamin A deficiency is a concern.
  • Specialty Applications: Research and development into new applications, such as in advanced skincare or functional foods with specific health claims, could unlock new revenue streams.
  • Production Efficiency: Investment in advanced manufacturing technologies, including continuous processing or AI-driven optimization, can improve cost competitiveness.

The market's reliance on established supply chains and stringent regulatory approvals necessitates thorough due diligence for any investment. The cost of raw materials, energy, and regulatory compliance are key financial considerations impacting margins.

Key Takeaways

• The global beta-carotene market is projected to reach $700 million by 2030, driven by the nutraceutical and food fortification sectors.
• Demand is balanced between dietary supplements (60%), food and beverages (30%), and animal feed (10%).
• Key market trends include a shift to natural ingredients, growth in nutraceuticals, and global fortification initiatives.
• Major producers include BASF, DSM, and ADISSEO, competing on quality, price, and supply reliability.
• Patent activity focuses on production efficiency, enhanced bioavailability, and novel applications.
• Regulatory frameworks like GRAS in the US and E160a in the EU govern its use, with regional variations requiring careful compliance.
• Investment opportunities lie in natural sourcing, bioavailability enhancement, emerging markets, and specialty applications.

Frequently Asked Questions

1. What is the primary differentiator between natural and synthetic beta-carotene in the market?

Natural beta-carotene is extracted from sources like algae or plants, often preferred by consumers seeking "clean label" products. Synthetic beta-carotene is chemically manufactured and typically offers cost advantages and greater consistency in purity for large-scale industrial applications.

2. How do bioavailability enhancements impact the market for beta-carotene?

Improved bioavailability allows for lower dosages to achieve the same or better vitamin A activity, potentially reducing formulation costs and appealing to consumers seeking more effective supplements. This innovation can create a competitive advantage.

3. What is the impact of fluctuating raw material prices on beta-carotene production costs?

The cost of raw materials, whether agricultural inputs for natural sources or petrochemicals for synthetic production, can significantly influence beta-carotene manufacturing costs. Supply chain disruptions or commodity price volatility directly affect producer margins.

4. Are there significant health risks associated with high beta-carotene intake?

While beta-carotene is generally safe, excessive intake, particularly from supplements, can lead to carotenemia, a harmless condition causing yellow-orange skin discoloration. Very high doses of beta-carotene from supplements (e.g., >20 mg/day) have been linked to an increased risk of lung cancer in smokers. Regulatory bodies set safe intake levels for different product categories.

5. How do global health initiatives against vitamin A deficiency affect beta-carotene demand?

These initiatives, often involving fortification of staple foods like flour or oil, directly increase the demand for beta-carotene as a Vitamin A precursor. This is a significant driver, especially in developing countries where deficiency is prevalent.